Information Library
Results for: Brochures - Clinical and marketing materials - Connect with investigators, regulators and physicians
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Clinical – Smarter Trials, Accelerated Outcomes
February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
Oversight Group Management Services - Aligned Action
February 2, 2011
From data monitoring committees and endpoint adjudication to core laboratory oversight, Quintiles provides a one-stop solution for managing oversight groups. -
Commercial – Identify, Promote and Prove Treatment Value
April 1, 2010
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. -
Risk Mitigation Programs
April 16, 2009
Risk mitigation measures can help keep valuable drugs on the market, even when their safety profile includes adverse events that might negatively affect the benefit risk balance. -
Risk Assessment & Strategy
April 16, 2009
Quintiles benefit risk analysis can help you anticipate potential regulatory concerns and highlight the benefit side of your drug’s benefit risk profile. -
Phase IIIb/IV Studies
April 16, 2009
New, more efficient delivery models help meet the increasing demands of Phase IIIB/IV Studies. -
Late Phase and Safety Services
April 10, 2009
Recent and pending regulatory changes have created an atmosphere of watchful waiting throughout the industry. While it may seem premature to initiate post-marketing studies to collect more “intelligent” safety data, Quintiles Late Phase & Safety Services anticipates that the need for expanded studies will soon spread.
Page 1 of 1 (7 results)
